Bleeding Ulcer – A Complete Patient Guide

Overview

A bleeding ulcer is a peptic ulcer (most often located in the stomach or duodenum) that has eroded into a blood vessel, causing gastrointestinal (GI) bleeding. The blood loss can be occult (only detectable on laboratory testing) or massive enough to produce visible vomiting of blood (hematemesis) or black, tarry stools (melena).

Peptic ulcers affect up to 4–10 % of the global adult population. Of those, 10–20 % will develop a bleed at some point, and ulcer‑related bleeding accounts for roughly 30–40 % of all acute upper GI hemorrhages. While ulcers can occur at any age, bleeding is most common in adults over 50, particularly men, smokers, and people who regularly use non‑steroidal anti‑inflammatory drugs (NSAIDs).

Symptoms

Bleeding ulcers may present with a range of signs, from subtle to life‑threatening.

• Upper abdominal pain – burning or gnawing sensation, often 2–3 hours after a meal; may improve with antacids.
• Hematemesis – vomiting of bright red blood or “coffee‑ground” material (partially digested blood).
• Melena – black, tarry stools indicating digested blood; may be accompanied by a foul odor.
• Occult blood loss – positive fecal occult blood test without visible bleeding; may cause iron‑deficiency anemia.
• Fatigue, weakness, or dizziness – result of anemia or acute blood loss.
• Shortness of breath or rapid heart rate (tachycardia) – especially during a significant bleed.
• Pallor – pale skin, especially on the lips and nail beds.
• Syncope or near‑syncope – fainting episodes due to sudden blood volume loss.
• Weight loss or loss of appetite – chronic ulcers can reduce food intake.

Because some patients (especially the elderly) may have “silent” bleeds, routine blood work (CBC, iron studies) is often the first clue.

Causes and Risk Factors

Primary Causes

• Helicobacter pylori infection – the most common bacterial cause; the organism damages the mucosal lining and increases gastric acid secretion.
• Regular use of NSAIDs (e.g., ibuprofen, naproxen, aspirin) – inhibit prostaglandin production, weakening the protective mucus barrier.
• Use of anticoagulant or antiplatelet medication (warfarin, direct oral anticoagulants, clopidogrel) – impair clot formation and may precipitate bleeding from a pre‑existing ulcer.

Additional Risk Factors

• Age > 50 years
• Male gender (approximately 2:1 male‑to‑female ratio)
• Smoking – nicotine increases gastric acid and impairs mucosal healing.
• Heavy alcohol consumption – alcohol irritates the gastric lining and can worsen H. pylori infection.
• Chronic stress or severe physiological stress (e.g., major surgery, burns, sepsis) – can produce “stress ulcers”.
• Corticosteroid therapy – synergistic with NSAIDs in damaging the mucosa.
• Family history of peptic ulcer disease.

Diagnosis

Diagnosing a bleeding ulcer involves confirming the presence of an ulcer and identifying active bleeding. The approach combines clinical assessment, laboratory testing, and imaging.

Initial Evaluation

• History & Physical Exam – focus on pain pattern, medication use, bleeding signs, and hemodynamic stability.
• Vital signs – hypotension or tachycardia suggest significant blood loss.
• Laboratory tests:
  • Complete blood count (CBC) – assesses hemoglobin/hematocrit.
  • Blood urea nitrogen (BUN) & creatinine – an elevated BUN/creatinine ratio (>20:1) can indicate upper GI bleed.
  • Serum iron, ferritin, and total iron‑binding capacity – evaluate chronic blood loss.
  • Coagulation profile (PT/INR, aPTT) – especially if the patient is on anticoagulants.

Upper Endoscopy (Esophagogastroduodenoscopy – EGD)

EGD is the gold‑standard test. It allows direct visualization, classification of ulcer size and stigmata of recent hemorrhage, and therapeutic interventions (e.g., clipping, injection, cautery). According to the American Society for Gastrointestinal Endoscopy, an urgent (<24 h) endoscopy reduces mortality in high‑risk patients.

Imaging (when endoscopy is not immediately available)

• Tagged red blood cell scan – detects active bleeding rates as low as 0.1 mL/min.
• CT angiography – quickly locates active bleeding (>0.5 mL/min) and guides interventional radiology.

Additional Tests

• Rapid urease test or stool antigen test for H. pylori (if not done during endoscopy).
• Serology for H. pylori in patients with bleeding ulcers where endoscopic biopsies are unsafe.

Treatment Options

Therapy aims to stop bleeding, eradicate underlying causes, and promote ulcer healing.

Acute Hemostasis

1. Endoscopic therapy – performed during the diagnostic EGD:
   • Injection of epinephrine (1:10 000) around the bleeding site.
   • Thermal coagulation (heater probe or bipolar cautery).
   • Mechanical clipping or band ligation.
   • Topical hemostatic powders (e.g., Hemospray) for diffuse oozing.
2. Angiographic embolization – interventional radiology can coil or embolize a bleeding vessel when endoscopy fails or is contraindicated.
3. Surgical intervention – rare; reserved for uncontrolled hemorrhage or perforated ulcer.

Pharmacologic Therapy

• Proton pump inhibitors (PPIs) – high‑dose IV omeprazole or pantoprazole continues for 72 h, then oral maintenance (e.g., 20–40 mg daily). PPIs raise gastric pH, stabilizing clots and promoting healing.
• H. pylori eradication – triple therapy (PPI + clarithromycin + amoxicillin/metronidazole) for 14 days, or quadruple therapy if resistance is suspected. Successful eradication reduces re‑bleed risk by ~70 % (NIH).
• Discontinue or adjust NSAIDs/antiplatelets – substitute with acetaminophen for pain, or switch to a COX‑2 selective NSAID with a PPI if NSAIDs are essential.
• Anticoagulation management – reverse agents (e.g., vitamin K, prothrombin complex concentrate) may be needed, followed by a carefully timed re‑initiation based on bleeding risk.

Lifestyle & Supportive Measures

• IV fluids or blood transfusion to maintain hemodynamic stability (target hemoglobin ≥ 7–8 g/dL for most patients).
• Avoid alcohol and smoking during the acute phase.
• Gradual re‑introduction of oral intake – start with clear liquids, advance as tolerated.

Living with Bleeding Ulcer

Even after the acute episode resolves, long‑term management reduces recurrence.

Medication Adherence

• Take PPIs exactly as prescribed; don’t skip doses.
• Complete the full course of H. pylori therapy, even if symptoms improve.
• Keep a medication list and share it with every new health‑care provider.

Dietary Guidance

• Eat smaller, frequent meals rather than large meals.
• Limit foods that increase acid or irritate the stomach (spicy foods, citrus, tomato‑based sauces, caffeine, chocolate).
• Incorporate soothing foods: oatmeal, bananas, boiled potatoes, low‑fat dairy.
• Stay hydrated but avoid carbonated beverages that can cause bloating.

Lifestyle Modifications

• Quit smoking – counseling, nicotine replacement, or prescription aid (bupropion, varenicline).
• Limit alcohol – no more than 1 drink per day for women, 2 for men; consider abstinence if ulcers recur.
• Manage stress through relaxation techniques, mindfulness, or mild exercise (walking, yoga).

Follow‑up Care

• Repeat endoscopy in 8–12 weeks if ulcer was large (>2 cm), had a visible vessel, or if symptoms persist.
• Routine CBC every 3–6 months for the first year to monitor for anemia.
• Annual H. pylori testing after eradication therapy to ensure cure (especially if symptoms recur).

Prevention

Preventing a bleeding ulcer begins with reducing ulcer formation and protecting the gastric mucosa.

• Test and treat H. pylori in anyone with dyspepsia, especially before starting long‑term NSAIDs.
• Use the lowest effective NSAID dose and always pair with a PPI or H2‑blocker if NSAIDs are required long‑term.
• Regularly review anticoagulant/antiplatelet therapy with your physician; consider dose adjustment or gastro‑protective agents.
• Adopt a balanced diet rich in fruits, vegetables, and whole grains that provide antioxidants and promote mucosal health.
• Maintain a healthy weight – obesity raises intra‑abdominal pressure and can exacerbate reflux.
• Schedule routine health checks for blood pressure, cholesterol, and diabetes, as systemic disease can affect ulcer healing.

Complications

If a bleeding ulcer is not promptly treated, several serious complications may arise:

• Severe hemorrhage leading to hypovolemic shock, multi‑organ failure, and death.
• Perforation – a hole through the stomach or duodenal wall causing peritonitis; requires emergent surgery.
• Penetration – ulcer extends into adjacent organs (e.g., pancreas, liver) causing localized pain and inflammation.
• Gastric outlet obstruction – chronic ulcer scarring narrows the pylorus, causing vomiting and weight loss.
• Stricture formation – narrowing of the GI lumen leading to dysphagia or feeding difficulties.
• Re‑bleeding – occurs in up to 15 % of patients within 30 days despite therapy; carries higher mortality.
• Iron‑deficiency anemia – chronic low‑grade blood loss can cause fatigue, reduced exercise tolerance, and heart strain.

When to Seek Emergency Care

References

• Mayo Clinic. “Peptic ulcer disease.” https://www.mayoclinic.org
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Peptic Ulcer.” https://www.niddk.nih.gov
• American College of Gastroenterology. “Management of Bleeding Peptic Ulcers.” https://gi.org
• Cleveland Clinic. “Upper GI Bleeding.” https://my.clevelandclinic.org
• World Health Organization. “Helicobacter pylori.” https://www.who.int
• Centers for Disease Control and Prevention. “Gastrointestinal Diseases.” https://www.cdc.gov